Updated:
Trillium Therapeutics Inc.
Trillium Therapeutics Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001616212, and its reported...
Overview
Trillium Therapeutics Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001616212, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-03-18, it reported annual revenue of USD 148,000; net income of USD -59,346,000; total assets of USD 300,822,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Trillium Therapeutics Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Mississauga, Canada
- Incorporated in
- A1
- Fiscal year end
- December 31
- SEC CIK
- 0001616212
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2020USD | $148,000 | -$59.3M | $300.8M | $247.6M | -$22.7M | |
| FY2019USD | $124,000 | -$41.6M | $25.4M | $14.6M | -$24.9M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Trillium Therapeutics Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.